Daniel DeNeui is a highly respected entrepreneur and executive known for his strategic planning, business development, and sales coaching expertise. His deep understanding of human behavior and psychology and his exceptional public speaking abilities have helped him launch and grow several multi-million dollar businesses, each starting with minimal initial capital. As the CEO of EVEXIAS Health Solutions®, Daniel leads an organization at the forefront of medical wellness. He focuses on revitalizing healthcare practices and improving the quality of patient care. His leadership has been instrumental in integrating innovative health and wellness approaches that significantly benefit practitioners and patients. He and his spouse shape the strategic direction of EVEXIAS and its affiliate, FarmaKeio, aiming to transform healthcare by enhancing educational, therapeutic, and business solutions. Since assuming the CEO role in 2015, his extensive experience in science and business management has been vital in advancing the company’s service offerings. He has been pivotal in developing significant therapies and products, such as the EvexiPEL® Method, PeptideSolutions™, and NutraceuticalSolutions™, which have all contributed to the field of medical wellness. At EVEXIAS, Daniel is dedicated to creating personalized wellness plans that utilize an integrative and functional approach. These plans are designed to address the root causes of health issues, focusing mainly on symptoms associated with hormone imbalances. By employing treatments like bioidentical hormone replacement therapy and advanced nutraceuticals, he ensures that each plan is tailored to meet the unique needs of the patients. Under his guidance, EVEXIAS has also made significant technological strides. In 2022, Daniel launched EVEXIAS Online, an innovative platform that enhances healthcare providers' educational experiences. This platform facilitates community building, complex case discussions, and access to research and educational resources. Moreover, in early 2023, he led the company’s most extensive training session, focusing on practical hormone therapy applications and enhancing practitioners' skills. Before his leadership at EVEXIAS, Daniel held significant roles at Asperio Labs and BioTE Medical, where he concentrated on optimizing hormone therapies and promoting healthy aging. His career also includes impactful tenures at Independent Producers of America and Cornerstone America, where he led strategic sales and business development efforts. Daniel DeNeui’s academic background in organic chemistry from Clemson University has underpinned his diverse professional achievements. Beyond his corporate responsibilities, he is a committed philanthropist, actively supporting charitable organizations that assist families facing unexpected challenges.